FDA inspection
ICU Medical Inc: FDA inspection ending Mar 1, 2006
FDA inspection 417255 · No Action Indicated (NAI) · Austin, TX
Key facts
| Inspection ID | 417255 |
|---|---|
| Firm | ICU Medical Inc |
| FEI number | 1628454 |
| Address | 3900 Howard Ln |
| City | Austin |
| State | TX |
| ZIP | 78728-6515 |
| Fiscal year | 2006 |
| Inspection end date | Mar 1, 2006 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs|Monit of Marketed Animal Drug,Feed &Dev|Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data